Burden of herpes zoster: The direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Blein, Cecile ^a   Gavazzi, Gaetan ^b   Paccalin, Marc ^c   Baptiste, Charles ^d   Berrut, Gilles ^e   Vainchtock, Alexandre ^a  

^a HEVA   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d SANOFI PASTEUR   (France)

^e CHU DE NANTES   (France)

Author keywords

Direct cost; French; Herpes Zoster; Hospitalization; Indirect cost

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMORBIDITY; DIABETES MELLITUS; ENDOCRINE DISEASE; FEMALE; FRANCE; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; VERY ELDERLY; CARDIOVASCULAR DISEASES; DIGESTIVE SYSTEM DISEASES; ECONOMICS; ENCEPHALITIS, VARICELLA ZOSTER; FACTUAL DATABASE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; MIDDLE AGED; MUSCULOSKELETAL DISEASES; PATIENT; RESPIRATORY TRACT DISEASES; STATISTICS AND NUMERICAL DATA; VARICELLA ZOSTER VIRUS;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; DATABASES, FACTUAL; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASES; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; FRANCE; HEALTH CARE COSTS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; PATIENTS; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES;

EID: 84939484703     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1059-9     Document Type: Article

References (43)

1. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of Herpes Zoster. Clin Infect Dis. 2007;44(Supplement 1):S1-S26.
2. Wallace MS, Oxman MN. Acute herpes zoster and postherpetic neuralgia. Anesthesiology Clinics of North America. 1997;2(13):371-405.
3. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc Mayo Clin. 2009;84(3):274-80.
4. Forbes HJ, Bhaskaran K, Thomas SL, et al. Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014;348:g2911. doi: 10.1136/bmj.g2911 .
5. Shingles (Herpes Zoster) Clinical Overview. Centers Dis. Control Prev. 2012. http://www.cdc.gov/shingles/hcp/clinical-overview.html (assessed on 17 august 2015)
6. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271-84.
7. Nagasako EM, Johnson RW, Griffin DRJ, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol. 2002;46(6):834-9.
8. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341-9.
9. Yawn BP, Wollan PC, St. Sauver JL, Butterfield LC. Herpes zoster Eye complications: rates and trends. Mayo Clin Proc. 2013;88(6):562-70.
10. Schiffner-Rohe J, Jow S, Lilie HM, Köster I, Schubert I. Herpes zoster in Germany. A retrospective analyse of SHL data. MMW Fortschr Med. 2010;151 Suppl 4:193-7.
11. Helgason S, Sigurdsson JA, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Pr. 1996;2(1):12-6.
12. Pinchinat S, Cebrián-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170.
13. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833. doi: 10.1136/bmjopen-2014-004833 .
14. Rimland D, Moanna A. Increasing incidence of herpes zoster among veterans. Clinical Infectious Diseases. 2010;50:1000-5.
15. Yawn BP, Wollan PC, Kurland MJ, St. Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86(2):88-93.
16. Réseau Sentinelles. Bilan annuel 2009 - Rapport d'activité. Paris; 2009 déc.
17. Réseau Sentinelles. Bilan annuel 2010 - Rapport d'activité. Paris; 2010 déc.
18. Réseau Sentinelles. Bilan annuel 2011 - Rapport d'activité. Paris; 2011 déc.
19. Réseau Sentinelles. Bilan annuel 2012 - Rapport d'activité. Paris; 2012 déc.
20. Gonzalez Chiappe S, Sarazin M, Turbelin C, Lasserre A, Pelat C, Bonmarin I, et al. Herpes zoster: burden of disease in France. Vaccine. 2010;28(50):7933-8.
21. Riou C, Rouget F, Sinteff J, et al. Outil de contrôle d'exhaustivité des cas pour le registre des malformations congénitales de Bretagne à partir des données PMSI. Journées EMOIS Nancy. 2013
22. Buisson G. Redressement du Programme de médicalisation des systèmes d'informations (PMSI). Direction de la recherche, des études, de l'évaluation et des statistiques; 2005 Mar 1. Report No.: 80.
23. Haut conseil de la Santé Publique. Les systèmes d'information pour la santé publique. November 2009. [ http://www.ladocumentationfrancaise.fr/rapports-publics/104000182/index.shtml ] (Accessed august 2015).
24. Quantin C, Cottenet J, Vuagnat A, Benzenine E, Fresson J, Prunet C, et al. Validité des données périnatales issues du pmsi: comparaison avec les données de l'enquête nationale périnatale 2010. Rev Epidemiol Sante Publique. 2013;61:S6.
25. Bernier M-O, Mezzarobba M, Maupu E, Caër-Lorho S, Brisse HJ, Laurier D, et al. Role of French hospital claims databases from care units in epidemiological studies: the example of the « Cohorte Enfant Scanner » study. Rev Epidemiol Sante Publique. 2012;60(5):363-70.
26. Hafdi-Nejjari Z, Couris C-M, Schott A-M, Schot A-M, Perrot L, Bourgoin F, et al. Role of hospital claims databases from care units for estimating thyroid cancer incidence in the Rhône-Alpes region of France. Rev Epidemiol Sante Publique. 2006;54(5):391-8.
27. Yancik R, Ershler W, Satariano W, Hazzard W, et al. Comorbidity: the ultimate geriatric syndrome: report of the National Institute on Aging Task Force on Comorbidity. J Gerontol A Biol Sci Med Sci. 2007;62(3):275-80.
28. Castle SC, Uyemura K, Rafi A, Akande O, Makinodan T. Comorbidity is a better predictor of impaired immunity than chronological age in older adults. J Am Geriatr Soc. 2005;53:1565-9.
29. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4(1):26-33.
30. Yang YW, Chen YH, Wang KH, Wang CY, Lin HW. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. CMAJ. 2011;183(5):E275-80.
31. Wu MY, Hsu YH, Su CL, Lin YF, Lin HW. Risk of herpes zoster in CKD: a matched-cohort study based on administrative data. Am J Kidney Dis. 2012;60(4):548-52.
32. Kuo CC, Lee CT, Lee IM, Ho SC, Yang CY. Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study. Am J Kidney Dis. 2012;59(3):428-33.
33. McDonald JR, Zeringue AL, Caplan L, Ranganathan P, Xian H, Burroughs TE, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009;48(10):1364-71.
34. Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4(12):1483-90.
35. Guignard AP, Greenberg M, Lu C, Rosillon D, Vannappagari V. Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006. Infection. 2014;42:729-35.
36. Cotton SJ, Belcher J, Rose P, Jagadeesan KS, Neal RD. The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study. Br J Cancer. 2013;108(3):721-6.
37. Chiu HF, Chen BK, Yang CY. Herpes zoster and subsequent risk of cancer: a population-based study. J Epidemiol. 2013;23(3):205-10.
38. Gil-Prieto R, San Martín M, de Andrés AL, Alvaro-Meca A, González A, de Miguel AG. Herpes zoster hospitalizations of patients with chronic illnesses in Spain, 1998-2004. Vacunas. 2011;12(3):95-101.
39. Chang CM, Woo E, Yu YL, Huang CY, Chin D. Herpes zoster and its neurological complications. Postgrad Med J. 1987;63(736):85-9.
40. Volpi A, Gross G, Hercogova J, Johnson RW. Current management of herpes zoster: the European view. Am J Clin Dermatol. 2005;6(5):317-25.
41. Sawyer AR, Williams G. Misdiagnosis of burns: herpes zoster ophthalmicus. J Burn Care Res. 2006;27(6):914-6.
42. Lin H-C, Chien C-W, Ho J-D. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74(10):792-7.
43. Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38-47.